Valuation of the use of biomarkers predictive of drug efficacy to enrich responders in oncology drug clinical development

Valuation of the use of biomarkers predictive of drug efficacy to enrich responders in oncology drug clinical development

Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (S.M.)--Massachusetts Institute of Technology, Sloan School of Management, 2006. === Includes bibliographical references (leaves 57-59). === I study several aspects of the value in performing oncology clinical trials using s...

Full description

Bibliographic Details
Main Author: Wine, David
Other Authors: A. Gregory Sorensen and Teodro Forcht Dagi.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2007
Subjects:
Harvard University > MIT Division of Health Sciences and Technology.
Sloan School of Management.
Online Access:http://hdl.handle.net/1721.1/35679

Internet

http://hdl.handle.net/1721.1/35679

Similar Items